» Articles » PMID: 35001370

Multiparameter Platelet Function Analysis of Bleeding Patients with a Prolonged Platelet Function Analyser Closure Time

Abstract

Patients referred for evaluation of bleeding symptoms occasionally have a prolonged platelet function analyser (PFA) closure time, without evidence for von Willebrand disease or impaired platelet aggregation. The aim of this study was to establish a shear-dependent platelet function defect in these patients. Patients were included based on high bleeding score and prior PFA prolongation. Common tests of von Willebrand factor (VWF) and platelet function and exome sequencing were performed. Microfluidic analysis of shear-dependent collagen-induced whole-blood thrombus formation was performed. In 14 PFA-only patients, compared to healthy volunteers, microfluidic tests showed significantly lower platelet adhesion and thrombus formation parameters. This was accompanied by lower integrin activation, phosphatidylserine exposure and P-selectin expression. Principal components analysis indicated VWF as primary explaining variable of PFA prolongation, whereas conventional platelet aggregation primarily explained the reduced thrombus parameters under shear. In five patients with severe microfluidic abnormalities, conventional platelet aggregation was in the lowest range of normal. No causal variants in Mendelian genes known to cause bleeding or platelet disorders were identified. Multiparameter assessment of whole-blood thrombus formation under shear indicates single or combined effects of low-normal VWF and low-normal platelet aggregation in these patients, suggesting a shear-dependent platelet function defect, not detected by static conventional haemostatic tests.

Citing Articles

Bleeding disorder of unknown cause: an illustrated review on current practice, knowledge gaps, and future perspectives.

Monard A, Mussert C, van Duijl T, Kruip M, Henskens Y, van den Biggelaar M Res Pract Thromb Haemost. 2024; 8(8):102625.

PMID: 39687924 PMC: 11648783. DOI: 10.1016/j.rpth.2024.102625.


Modelling arterial thrombus formation in vitro.

Drysdale A, Zaabalawi A, Jones S Curr Opin Hematol. 2023; 31(1):16-23.

PMID: 37823547 PMC: 10715692. DOI: 10.1097/MOH.0000000000000789.


Multiparameter platelet function analysis of bleeding patients with a prolonged platelet function analyser closure time.

Heubel-Moenen F, Brouns S, Herfs L, Boerenkamp L, Jooss N, Wetzels R Br J Haematol. 2022; 196(6):1388-1400.

PMID: 35001370 PMC: 9303561. DOI: 10.1111/bjh.18003.

References
1.
Downes K, Megy K, Duarte D, Vries M, Gebhart J, Hofer S . Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders. Blood. 2019; 134(23):2082-2091. PMC: 6993014. DOI: 10.1182/blood.2018891192. View

2.
van Kruchten R, Cosemans J, Heemskerk J . Measurement of whole blood thrombus formation using parallel-plate flow chambers - a practical guide. Platelets. 2012; 23(3):229-42. DOI: 10.3109/09537104.2011.630848. View

3.
Gresele P . Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH. J Thromb Haemost. 2014; 13(2):314-22. DOI: 10.1111/jth.12792. View

4.
Lehmann M, Ashworth K, Manco-Johnson M, Di Paola J, Neeves K, Ng C . Evaluation of a microfluidic flow assay to screen for von Willebrand disease and low von Willebrand factor levels. J Thromb Haemost. 2017; 16(1):104-115. PMC: 5794217. DOI: 10.1111/jth.13881. View

5.
Norman J, Westbury S, Jones M, Mumford A . How should we test for nonsevere heritable platelet function disorders?. Int J Lab Hematol. 2014; 36(3):326-33. DOI: 10.1111/ijlh.12211. View